{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:08:40Z","timestamp":1779923320554,"version":"3.53.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-026-02150-0","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:29:09Z","timestamp":1776396549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between volume per injection and treatment failure after water vapor thermal therapy"],"prefix":"10.1186","volume":"26","author":[{"given":"Takashi","family":"Okabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"issue":"Suppl 9","key":"2150_CR1","first-page":"S3","volume":"7","author":"CG Roehrborn","year":"2005","unstructured":"Roehrborn CG. Benign prostatic hyperplasia: an overview. Rev Urol. 2005;7(Suppl 9):S3\u201314.","journal-title":"Rev Urol"},{"issue":"6","key":"2150_CR2","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","volume":"67","author":"C Gratzke","year":"2015","unstructured":"Gratzke C, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015;67(6):1099\u2013109.","journal-title":"Eur Urol"},{"issue":"4","key":"2150_CR3","first-page":"154","volume":"21","author":"EM Bortnick","year":"2019","unstructured":"Bortnick EM, Simma-Chiang V, Kaplan SA. Long-term consequences of medical therapy for benign prostatic hyperplasia. Rev Urol. 2019;21(4):154\u20137.","journal-title":"Rev Urol"},{"issue":"6","key":"2150_CR4","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.eururo.2023.02.028","volume":"83","author":"JN Cornu","year":"2023","unstructured":"Cornu JN, et al. Minimally invasive treatments for benign prostatic obstruction: a systematic review and network meta-analysis. Eur Urol. 2023;83(6):534\u201347.","journal-title":"Eur Urol"},{"issue":"30","key":"2150_CR5","doi-asserted-by":"publisher","first-page":"e21365","DOI":"10.1097\/MD.0000000000021365","volume":"99","author":"LE Miller","year":"2020","unstructured":"Miller LE, et al. Water vapor thermal therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: systematic review and meta-analysis. Med (Baltim). 2020;99(30):e21365.","journal-title":"Med (Baltim)"},{"key":"2150_CR6","doi-asserted-by":"publisher","unstructured":"OkabeT. A single\u2013office experience of day\u2013case water vapor thermal therapy for benign prostatic hyperplasia. World Acad Sci J. 2024;6(4). https:\/\/doi.org\/10.3892\/wasj.2024.249.","DOI":"10.3892\/wasj.2024.249"},{"issue":"10","key":"2150_CR7","first-page":"e95347","volume":"17","author":"T Okabe","year":"2025","unstructured":"Okabe T. One-year clinical outcomes of water vapor thermal therapy for benign prostatic hyperplasia: a single-center experience of 52 patients. Cureus. 2025;17(10):e95347.","journal-title":"Cureus"},{"key":"2150_CR8","first-page":"159","volume":"9","author":"MF Darson","year":"2017","unstructured":"Darson MF, et al. Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rez\u016bm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Res Rep Urol. 2017;9:159\u201368.","journal-title":"Res Rep Urol"},{"issue":"5","key":"2150_CR9","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.juro.2015.10.181","volume":"195","author":"KT McVary","year":"2016","unstructured":"McVary KT, et al. Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2016;195(5):1529\u201338.","journal-title":"J Urol"},{"key":"2150_CR10","first-page":"71","volume":"10","author":"HH Woo","year":"2017","unstructured":"Woo HH, Gonzalez RR. Perspective on the Rez\u016bm(\u00ae) System: a minimally invasive treatment strategy for benign prostatic hyperplasia using convective radiofrequency water vapor thermal therapy. Med Devices (Auckl). 2017;10:71\u201380.","journal-title":"Med Devices (Auckl)"},{"issue":"1","key":"2150_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.urology.2015.03.021","volume":"86","author":"LA Mynderse","year":"2015","unstructured":"Mynderse LA, et al. Rez\u016bm system water vapor treatment for lower urinary tract symptoms\/benign prostatic hyperplasia: validation of convective thermal energy transfer and characterization with magnetic resonance imaging and 3-dimensional renderings. Urology. 2015;86(1):122\u20137.","journal-title":"Urology"},{"issue":"2","key":"2150_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/end.2022.0390","volume":"37","author":"M Babar","year":"2023","unstructured":"Babar M, et al. Rezum outcomes in relationship to number of injections: is less more? J Endourol. 2023;37(2):157\u201364.","journal-title":"J Endourol"},{"key":"2150_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.urology.2022.01.039","volume":"165","author":"O Aladesuru","year":"2022","unstructured":"Aladesuru O, et al. Pilot study of less is more rezum for treatment of BPH. Urology. 2022;165:256\u201360.","journal-title":"Urology"},{"issue":"1","key":"2150_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00345-025-05793-0","volume":"43","author":"M Samir","year":"2025","unstructured":"Samir M, et al. A comparative analysis of the outcomes of Rez\u016bm therapy based on prostate size: a four-year retrospective analysis. World J Urol. 2025;43(1):443.","journal-title":"World J Urol"},{"issue":"7","key":"2150_CR15","doi-asserted-by":"publisher","first-page":"501824","DOI":"10.1016\/j.acuro.2025.501824","volume":"49","author":"I Schwartzmann","year":"2025","unstructured":"Schwartzmann I, et al. Injection density in Rez\u016bm\u00ae: Less might not be more. A multicentric international study. Actas Urol Esp (Engl Ed). 2025;49(7):501824.","journal-title":"Actas Urol Esp (Engl Ed)"},{"issue":"2","key":"2150_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/luts.12083","volume":"8","author":"YH Ko","year":"2016","unstructured":"Ko YH, Song PH. Structural variation of prostate urethra reflected by the ratio between prostate volume and prostatic urethral length is associated with the degrees of lower urinary tract symptoms. Low Urin Tract Symptoms. 2016;8(2):113\u20139.","journal-title":"Low Urin Tract Symptoms"},{"issue":"1","key":"2150_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.prnil.2018.06.002","volume":"7","author":"BS Kim","year":"2019","unstructured":"Kim BS, et al. Prostatic urethral length as a predictive factor for surgical treatment of benign prostatic hyperplasia: a prospective, multiinstitutional study. Prostate Int. 2019;7(1):30\u20134.","journal-title":"Prostate Int"},{"issue":"2","key":"2150_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/aja202357","volume":"26","author":"GM Busetto","year":"2024","unstructured":"Busetto GM, et al. Minimally invasive surgical therapies (MISTs) for lower urinary tract symptoms (LUTS): promise or panacea? Asian J Androl. 2024;26(2):135\u201343.","journal-title":"Asian J Androl"},{"issue":"1","key":"2150_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00345-024-05127-6","volume":"42","author":"P Annese","year":"2024","unstructured":"Annese P, et al. UroLift to preserve seminal parameters in young male with LUTS from BPH. World J Urol. 2024;42(1):486.","journal-title":"World J Urol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02150-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02150-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02150-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:54:19Z","timestamp":1779922459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02150-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2150"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02150-0","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was submitted to and approved by the Ethics Committee of Medical Corporation Koshin-Kai (approval number: KS1003). The requirement to obtain informed consent was waived by the Ethics Committee owing to the retrospective nature of the study. This study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}